16.4
Sonoma Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
Assets
(positive)
Change from FY22 to FY26
millions USD
FY22:
FY23:
13.8
FY24:
12.5
FY25:
12.6
FY26:
12.1
(positive)
Change from FY22 to FY26
millions USD
FY22:
2.42
FY23:
2.43
FY24:
2.19
FY25:
1.05
FY26:
1.86
Total assets
Change from FY22 to FY26
millions USD
FY22:
18.8
FY23:
16.2
FY24:
14.7
FY25:
13.7
FY26:
14.0
Liabilities & Equity
(negative)
Change from FY22 to FY26
millions USD
FY22:
5.82
FY23:
3.72
FY24:
3.72
FY25:
4.10
FY26:
4.83
(negative)
Change from FY22 to FY26
millions USD
FY22:
4.33
FY23:
4.54
FY24:
4.88
FY25:
5.19
FY26:
6.03
(positive)
Change from FY22 to FY26
millions USD
FY22:
8.70
FY23:
7.98
FY24:
6.14
FY25:
4.41
FY26:
3.10
Total liabilities & equity
Change from FY22 to FY26
millions USD
FY22:
18.8
FY23:
16.2
FY24:
14.7
FY25:
13.7
FY26:
14.0
All amounts in millions USD